Hi,
I know during ANDA filing the formulation maker has to identify the API source.
For the drugs that are coming off patent, Is there anyway to find out how many formulation makers are using Neuland as API source ?? I see that only as any hope to see topline growth.
Also,
One question is that why do formulation makers buy API from other when they can produce it themselves ?
| Subscribe To Our Free Newsletter |
